PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8878434-2	1996	We wondered if insulin or IGF-I induced expression of alpha1 adrenergic receptors in vascular smooth muscle cells (VSMCs) which could enhance smooth muscle contraction and cell growth activated by catecholamines.	Catecholamines	197-211	insulin-like growth factor 1	Rattus norvegicus	26-31	
8878434-8	1996	These results suggest that insulin/IGF-I regulate expression of alpha1 receptors in VSMCs and potentially enhance the effects of catecholamines in settings of hyperinsulinemia.	Catecholamines	129-143	insulin-like growth factor 1	Rattus norvegicus	35-40	
26399932-14	2016	CONCLUSION: IGF-1 treatment attenuates diastolic and systolic dysfunction associated with chronic catecholamine-induced cardiomyopathy while preserving adrenergic sensitivity and promoting BH4 production.	Catecholamines	98-111	insulin-like growth factor 1	Rattus norvegicus	12-17